Infertility Clinical Trial
Official title:
Prospective Randomized Controlled Trial Comparing Two Different Embryo Transfer (ET) Catheters
Numerous published trials now document that the embryo transfer (ET) procedure has a huge
impact on pregnancy and delivery rates after IVF (In Vitro Fertilization).
To compare the ease of use (defined as the rate of successful atraumatic insertion) of
different types of embryo transfer (ET) catheters.
This prospective randomized unblinded controlled clinical trial is performed to determine if
there is any difference in ease of use among 2 different catheters : Cook k-soft-5000, Cook
K-JETS-551910-S.
Inclusion criteria: patients < / = 38 years of age, body mass index (BMI) between 18 and 28,
at least one frozen-thawed blastocyst transferred.
Exclusion criteria: ICSI (Intracytoplasmic Sperm Injection)-TESE (Testicular Sperm
Extraction) IVF cycles.
A number of 352 consecutive women undergoing embryo transfer will be selected for this
prospective, randomized controlled trial. Two protocols for endometrial preparation will be
used before frozen/thawed blastocyst transfer: the modified spontaneous protocol and the
oral/transdermal preparation protocol. ET will be done with patient in lithotomy position,
under ultrasound guidance. No anesthesia will be used for the procedure.
176 patients will be enrolled in this trial and randomized to enter one of the two catheter
group.
Introduction
Embryo transfer (ET) is the final and critical step in the long pathway of in vitro
fertilization (IVF) treatment. Implantation is a complex process and, as yet, one not fully
understood. Aside from the quality of the embryos replaced and the receptivity of the
endometrium, the embryo transfer procedure itself might impact the implantation process.
The procedure has changed very little since the first descriptions. Numerous data suggest
that difficult transfers should be avoided, as they are likely to reduce the chances of
implantation and subsequent pregnancy rates.
It has been proposed on the basis of small studies that traumatic embryo transfer can induce
uterine contractions capable of displacing the embryo or induce unwanted endometrial damage.
The evidence is unclear, however, as whilst several studies support this concept, others do
not.
Free hand embryo transfer with soft catheters under ultrasound guidance is considered the
best option in transferring embryos. Many retrospective trials have reported higher Pregnancy
Rates (PR) with soft catheters compared with hard catheters. However in technically difficult
ET, where difficulties are met in negotiating the cervical os, the use of harder catheters is
needed. The change from soft to hard catheters in these transfers, along with the difficulty
of the transfer itself, may account for differences in pregnancy rate.
On the other hand it is likely that the experience of the clinicians and their confidence
with the catheter are the main variables involved in this 'artistic' skill.
On the basis of a large recent RCT, variations in the PR may depend on variations between
operators and their confidence with different type of catheters.
The investigators work in a large teaching hospital where many different operators with
different levels of experience perform ET. The rate of difficult ET varies considerably
between operators (between 15% and 42%, median 30%) although the overall PR does not vary
significantly. With this study the investigators would like to point out whether or not there
is a catheter that is able to significantly reduce the difficult transfer rate. The secondary
outcome is to assess if one of the catheters is able to sensibly minimize the differences in
difficult transfer rate between operators.
Objective
Assessing differences in terms of difficult embryo-transfer rate among two different type of
catheter: Cook k-soft-5000 (or K-J-SP-681710 and K-J-SPPE-681710) and Cook K-JETS-551910-S.
In order to achieve a measurable difference in the ease of use of the two catheters we
decided to compare the median percentage of 'difficult transfer' for all the operators
performing the included ETs with the two different catheters. Moreover we aim to study the
percentage of difficult ET among operators with the two ET catheters in order to highlight if
different catheters may be associated to different interoperator variability in difficult ET
rate.
Materials and Methods 352 consecutive women undergoing frozen/thawed blastocyst transfer will
be selected for this prospective, randomized controlled trial. The frozen blastocysts result
from supernumerary embryos or from 'freeze all policy' in patients at high risk of Severe
Ovarian Hyperstimulation Syndrome (OHSS).
The randomization of the single patient to one of the two study branches will be done by the
nurse or the embryologist just before the procedure.
Endometrial preparation (modified spontaneous cycle and pharmacological endometrial
preparation) Modified Spontaneous cycle In patient with regular menses, the endometrial
thickness and dominant follicle diameter are monitored with transvaginal scan beginning on
day 8 since period onset. When preovulatory follicle reaches the mean diameter of at least 16
mm a vial of hCG (human Chorionic Gonadotropin) 5000 IU is administered subcutaneously,
intravaginal Progesterone is started 2 days later and the blastocyst transfer is scheduled 7
days after hCG injection.
Pharmacological Endometrial preparation In patient with irregular menses, endometrial
preparation with oral or transdermal oestradiol is prescribed and started on day 2 of the
period. Endometrial thickness and ovarian quiescence are monitored via transvaginal scan
starting on day 10-12 since the period onset. When endometrial thickness reaches a minimum of
7,5 mm, intravaginal progesterone is started and blastocyst transfer is performed 5 days
later.
Technique of ET On the day of ET, patient will be asked to come with a full bladder. ET will
be done with patient in lithotomy position. No anesthesia will be used for the procedure.
Under sterile condition, speculum is inserted to expose cervix, cervix will be cleaned with
sterile physiologic solution and gently draped.
The Et procedure itself is standardized as far as possible amongst the participating
physicians to eliminate bias.
Description of Transfer technique with the two different catheters.
- Catheter Cook K-Jets-551910-S consists of an outer firm and an inner ultrasoft catheter.
The outer guiding catheter (17 cm long) is slightly stiff, with a preshaped curve and a
rounded bulb tip to help negotiate the cervical canal. It has a depth marker at 4 cm
from the tip, which can be pulled back to a second marker at 5 cm. The inner catheter
(23 cm long) is made of a soft material with a rounded bullet tip. In general, the inner
catheter does not negotiate the cervical canal directly but rather is introduced into
the uterine cavity through the outer catheter.
- Catheter Cook k-soft-5000 (or K-J-SP-681710 and K-J-SPPE-681710): this catheter system
consists of an outer firm and inner soft catheter. The outer guiding catheter (15,4 cm
long) is straight and made of flexible material. The inner catheter (23 cm long) is made
of a very soft and flexible polyurethan. The inner catheter is introduced directly
through the cervix.
Easy transfers are defined as follows:
- Cook k-soft-5000 catheter: straight-forward advancing of the preloaded inner catheter
through the cervix, the internal os and the uterine cavity up to the site of embryo
release, chosen on the basis of an acceptable Ultrasound vision.
- Cook K-JETS-551910-S catheter: straight-forward advancement of the outer catheter
through the cervix up to the internal os followed by straight-forward advancement of the
inner loaded catheter from outer catheter tip to the site of embryo release, chosen on
the basis of acceptable Ultrasound vision.
Difficult transfers are defined as follow:
- Cook k-soft-5000 catheter (or K-J-SP-681710 and K-J-SPPE-681710): advancement of the
outer sheath, multiple attempts, force, required manipulation, use of a stylet or
tenaculum, dilatation;
- Cook K-JETS-551910-S catheter: required manipulation, multiple attempts, force, the use
of a stylet or tenaculum, dilatation.
Pregnancy assessment Clinical pregnancy will be defined as follows: a pregnancy diagnosed by
ultrasonographic visualization of one or more gestational sacs or definitive clinical signs
of pregnancy. It includes ectopic pregnancy. Live birth was defined as delivery of a living
baby after at least 24 weeks of gestation.
Numerosity The sample size has been calculated on the basis of historical difficult Et rate
registered in years 2014 and 2015.
In the period 01/01/2014-31/12/2015 a total of 1014 ET were performed. We calculated a 28 %
of difficult ET with a 30% median of difficult transfer rate among all operators and the
number of operators performing the procedure was 22.
In order to detect a 50 % difference in difficult ET rate (90% power), 352 patients need to
be enrolled in the study (176 patients per group).
Data Management The data collected on the ET will be registered in a specific database in
which each patient will be identified by an identification code.
Patients enrolled in this trial will have consented in writing that their medical records
could be used for research purposes, as long as the patients' anonymity was protected and
confidentiality of the medical record was assured.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT01977144 -
Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency
|
N/A |